Risk factors for infections caused by multidrug-resistant bacteria in patients with solid tumours

Scandinavian Journal of Infectious Diseases

Volumn 43, Issue 2, 2011, Pages 107-111

  Horasan, Elif Sahin ^a   Ersoz, Gulden ^a   Horoz, Mehmet ^a   Göksu, Musa ^a   Karacorlu, Sevim ^a   Kaya, Ali ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

Healthcare associated infection; MDR bacteria; Solid tumour

Indexed keywords

CEPHALOSPORIN; POLYPEPTIDE ANTIBIOTIC AGENT;

ACINETOBACTER; ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; ENTERITIS; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; PSEUDOMONADACEAE; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SOLID TUMOR; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; SURGERY; SURGICAL INFECTION; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TURKEY; YOUNG ADULT;

EID: 78751477765     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2010.534500     Document Type: Article

References (25)

1. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004. Am J Infect Control 2004;32:470-85
2. Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century - a clinical super-challenge. N Engl J Med 2009;360:439-43
3. McDonald LC. Trends in antimicrobial resistance in health care associated pathogens and effect on treatment. Clin Infect Dis 2006;42(Suppl 2):S65 - 71
4. Gaynes R, Edwards JR. Overview of nosocomial infections caused by Gram-negative bacilli. Clin Infect Dis 2004;41: 848-54
5. Ashour HM, El-Sharif A. Species distribution and antimicrobial susceptibility of Gram-negative aerobic bacteria in hospitalized cancer patients. J Transl Med 2009;7:14
6. Buke C, Armand-Lefevre L, Lolom I, Guerinot W, Deblangy C, Ruimy R, et al. Epidemiology of multidrug-resistant bacteria in patients with long hospital stays. Infect Control Hosp Epidemiol 2007;28:1255-60
7. Maragakis LL, Perencevich EN, Cosgrave SE. Clinical and economic burden of antimicrobial resistance. Expert Rev Infect Ther 2008;6:751-63
8. Salgado CD, O'Grady N, Farr BM. Prevention and control of antimicrobial-resistant infections in intensive care patients Crit Care Med 2005;33:2373-82
9. Danai PA, Moss M, Mannino DM, Martin GS. The epidemiology of sepsis in patients with malignancy. Chest 2006;129:1432-40
10. Williams MD, Braun LA, Cooper LM, Johnston J, Weiss RV, Qualy RL, et al. Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit Care 2004;8:R291 - 8
11. Ashour HM, El-Sharif A. Microbial spectrum and antibiotic susceptibility profile of Gram-positive aerobic bacteria isolated from cancer patients. J Clin Oncol 2007;25:5763-9
12. Bhorade SM, Christenson J, Pohlman AS, Arnow PM, Hall JB. The incidence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients. Chest 1999;115:1085-91
13. Vergis EN, Hayden MK, Chow JW, Snydman DR, Zervos MJ, Linden PK, et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. A prospective multicenter study. Ann Intern Med 2001;135:484-92
14. Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol 2008;61:1234-40
15. Horan TC, Andrus M, Dudeck MA. CDC/NHSN Surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting Am J Infect Control 2008;36:309-32
16. Gold HS, Moellering RC Jr. Antimicrobial-drug resistance N Engl J Med 1996;335:1445-53
17. Falagas ME, Kopterides P. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect 2006;64:7-15
18. Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006;42:692-9
19. Playford EG, Craig JC, Iredell JR. Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences J Hosp Infect 2007;65:204-11
20. Klevens RM, Edwards JR, Tenover FC, McDonald LC, Horan T, Gaynes R. Changes in the epidemiology of methicillin- resistant Staphylococcus aureus in intensive care units in US hospitals, 1992 - 2003. Clin Infect Dis 2006;42: 389-91
21. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials J Antimicrob Chemother 2002;49:999-1005
22. Fabbro-Peray P, Sotto A, Defez C, Cazaban M, Molinari L, Pinède M, et al. Mortality attributable to nosocomial infection: a cohort of patients with and without nosocomial infection in a French university hospital. Infect Control Hospital Epidemiol 2007;28:265-72
23. Shurland S, Zhan M, Bradham DD, Roghmann MC. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hospital Epidemiol 2007;28: 273-9
24. Zinn CS, Westh H, Rosdahl VT; Sarisa Study Group. An international multicenter study of antimicrobial resistance and typing of hospital Staphylococcus aureus isolates from 21 laboratories in 19 countries or states. Microb Drug Resist 2004;10:160-8
25. Blot S. Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units Clin Microb Infect 2008;14:5 - 13z